Reportlinker Adds Leading Anti-Cancer Drugs: World Market Prospects 2011-2021
NEW YORK, April 5, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
What will this decade hold for leading anti-cancer drugs and that therapeutic market? Our new report shows you anti-cancer drug revenue forecasts for 2011 to 2021. We provide research, data and opinions to benefit your work now.
What revenues will cancer treatment markets generate from 2011 to 2021? What gains will leading companies and products achieve? What sales trends will leading national markets - developed and developing - show?
Our study answers those questions and many others for anti-cancer agents. By ordering now, you can stay ahead. We aim to save you time and aid your decisions.
Anti-cancer drug sales exceeded $50bn worldwide in 2009, with impressive growth. Our report shows you where cancer therapies are heading from 2011 to 2021 - technology, competition and revenues.
Over 20 million new cases of cancer are predicted in 2025, compared with 12 million in 2008 (WHO). We show the potential for cancer treatments, existing and in development.
Our report shows you revenue forecasts at total world, sub-market, product and national levels. You can assess the potential of the anti-cancer drug industry and market now.
We show the industry's strengths, weaknesses, trends and opportunities from 2011. We show you oncology R&D trends - pipeline and emerging treatments to look out for.
In our repor